IL-36α induces maturation of Th1-inducing human MDDC and synergises with IFN-γ to induce high surface expression of CD14 and CD11c

Human Immunology

Volumn 76, Issue 4, 2015, Pages 245-253

  Higgins, John ^a   Mutamba, Shilla ^a   Mahida, Yashwant ^b   Barrow, Paul ^a   Foster, Neil ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

CD209; Dendritic cell; IFN ; IL 36R; IL 36

Indexed keywords

CD14 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 36 ALPHA; INTERLEUKIN 36 BETA; LIPOPOLYSACCHARIDE; T6 ANTIGEN; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C3B; INTERLEUKIN 1; INTERLEUKIN 36, HUMAN; PROTEIN BINDING;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MONOCYTE DERIVED DENDRITIC CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TH1 CELL; CELL CULTURE; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONOCYTE; SALMONELLOSIS; UPREGULATION;

ANTIGENS, CD11C; ANTIGENS, CD14; CELL DIFFERENTIATION; CELLS, CULTURED; COMPLEMENT C3B; DENDRITIC CELLS; DRUG SYNERGISM; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; LYMPHOCYTE ACTIVATION; MONOCYTES; PROTEIN BINDING; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TH1 CELLS; UP-REGULATION;

EID: 84933182770     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.01.012     Document Type: Article

References (26)

1. Mutamba S., Allison A., Mahida Y., Barrow P., Foster N. Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9. Eur. J. Immunol. 2012, 42:607-617.
2. Nakahara T., Urabe K., Fukagawa S., Uchi H., Inaba K., Furue M., et al. Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma. Clin. Exp. Immunol. 2005, 139:476-482.
3. Frasca L., Nasso M., Spensieri F., Fedele G., Palazzo R., Malavasi F., et al. IFN-gamma arms human dendritic cells to perform multiple effector functions. J. Immunol. 2008, 180:1471-1481.
4. Verhasselt V., Buelens C., Willems F., De Groote D., Haeffner-Cavaillon N., Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 1997, 158:2919-2925.
5. Zhou L.-J., Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 1995, 154:3821-3835.
6. Romani N., Reider D., Heuer M., Ebner S., Eibl B., Niederwieser D., et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods 1996, 196:137-151.
7. Kagaya K., Watnabe K., Fukazawa J. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect. Immun. 1989, 57:609-615.
8. Mastroeni P., Vasquez-Torres A., Fang F.C., Yisheng Y., Khan S., Hormaeche C.E., et al. Antimicrobial actions of NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival. J. Exp. Med. 2000, 192:237-247.
9. Vasquez-Torres A., Jones-Carson J., Mastroeni P., Ischiropoulous H., Fang F.C. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 2000, 192:227-236.
10. Foster N., Hulme S.D., Barrow P.A. Induction of antimicrobial pathways during early-phase immune response to Salmonella spp. in murine macrophages: gamma interferon (IFN-gamma) and upregulation of IFN-gamma receptor alpha expression are required for NADPH phagocytic oxidase gp91-stimulated oxidative burst and control of virulent Salmonella spp. Infect. Immun. 2003, 71:4733-4741.
11. Wick M.J. Innate immune control of Salmonella enterica Serovar Typhimurium: mechanisms contributing to combating systemic Salmonella infection. J. Innate Immunol. 2011, 3:543-549.
12. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
13. Naik S.H. Demystifying the development of dendritic cell subtypes, a little. Immunol. Cell Biol. 2008, 86:439-452.
14. Kielian T.L., Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology 1995, 29:187.
15. Malhotra V., Hogg N., Sim R.B. Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3). Eur. J. Immunol. 1986, 16:1117-1123.
16. Ingalls R.R., Golenbock D.T. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 1995, 181:1473-1479.
17. Vigne S., Palmer G., Lamacchia C., Martin P., Talabot-Ayer D., Rodriguez E., et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood 2011, 118:5813-5823.
18. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
19. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996, 4:407-414.
20. Jiang Q., Akashi S., Miyake K., Petty H.R. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB. J. Immunol. 2005, 166:3541-3544.
21. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., et al. CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4. Cell 2011, 147:868-880.
22. Landmann R., Knopf H.P., Link S., Sansano S., Schumann R., Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect. Immun. 1996, 64:1762-1769.
23. Meunier L., Bohjanen K., Voorhees J.J., Cooper K.D. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a β2 integrin critically involved in T-cell activation. J. Invest. Dermatol. 1994, 103:775-779.
24. Singh-Jasuja H., Thiolat A., Ribon M., Boissier M.C., Bessis N., Rammensee H.G., et al. The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering. Immunobiology 2013, 218:28-39.
25. Sándor N., Kristóf K., Paréj K., Pap D., Erdei A., Bajtay Z. CR3 is the dominant phagocytotic complement receptor on human dendritic cells. Immunobiology 2013, 218:652-663.
26. Ben Nasr A., Haithcoat J., Masterson J.E., Gunn J.S., Eaves-Pyles T., Klimpel G.R. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J. Leukoc. Biol. 2006, 80:774-786.